[1]李兴佳,徐书杭,刘超.雌激素及其受体与甲状腺癌的关系[J].国际内分泌代谢杂志,2016,36(04):273-276.[doi:10.3760/cma.j.issn.1673-4157.2016.04.15]
　Li Xingjia,Xu Shuhang,Liu Chao.Relationship between estrogen, its receptors and thyroid cancer[J].International Journal of Endocrinology and Metabolism,2016,36(04):273-276.[doi:10.3760/cma.j.issn.1673-4157.2016.04.15]
点击复制

雌激素及其受体与甲状腺癌的关系()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
36
期数:
2016年04期
页码:
273-276
栏目:
综述
出版日期:
2016-07-20

文章信息/Info

Title:
Relationship between estrogen, its receptors and thyroid cancer
作者:
李兴佳; 徐书杭; 刘超
210028 南京,中国中医科学院江苏分院,江苏省中医药研究院,南京中医药大学附属中西医结合医院,国家中医药管理局瘿病证治重点研究室
Author(s):
Li Xingjia;  Xu Shuhang;  Liu Chao
Jiangsu Branch of China Academy of Chinese Medical Science, Jiangsu Provincial Academy of Chinese Medicine, Jiangsu Province Hospital on Integration of Chinese and Western Medicine Affiliated to Nanjing University of Traditional Chinese Medicine, Key Laboratory of TCM Syndrome&Treatment of Yingbing of State Administration of Traditional Chinese Medicine, Nanjing 210028, China
关键词:
雌激素;  雌激素受体;  甲状腺癌
Keywords:
Estrogen;  Estrogen receptors;  Thyroid cancer
DOI:
10.3760/cma.j.issn.1673-4157.2016.04.15
摘要:
甲状腺癌的发病率近年来呈持续增长的态势,在生育年龄段内,女性甲状腺癌患病率显著高于男性,有学者推测,这种差异与女性体内较高的雌激素水平有着密不可分的关系。雌激素是一种类固醇激素,在人体内以雌二醇为主,通过与其受体结合而发挥相应的生物学效应,包括参与生长、分化、免疫调节等。雌激素主要由肾上腺皮质和卵巢分泌,但甲状腺也能少量分泌雌激素。有研究显示,甲状腺中存在雌激素及其受体,雌激素能够通过其受体在甲状腺癌的发生、发展中发挥作用。
Abstract:
An increasing incidence of thyroid cancer has been reported in recent years, and the frequency of thyroid cancer in female is significantly higher than that in male during the fertile age. Some scholars speculate that this difference has a close relationship with the higher level of estrogen in female. Estrogen is a kind of steroid hormone, the most important estrogen in human body is estradiol, it plays an important role via its receptors in proliferation, differentiation, immunity regulation and so on. Estrogen is mainly secreted by adrenal cortex and ovaries, but thyroid can also secret a small amount of estrogen. Previous studies have demonstrated the existence of estrogen and estrogen receptors in thyroid, and proved that estrogen may play an important role in the development and progression of thyroid cancer via estrogen receptors.

参考文献/References:

[1] Li N, Du XL, Reitzel LR, et al. Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008[J]. Thyroid, 2013, 23(1): 103-110. DOI: 10.1089/thy.2012.0392.
[2] Kilfoy BA, Devesa SS, Ward MH, et al. Gender is an age-specific effect modifier for papillary cancers of the thyroid gland[J]. Cancer Epidemiol Biomarkers Prev, 2009, 18(4): 1092-1100. DOI: 10.1158/1055-9965.
[3] Santin AP, Furlanetto TW. Role of estrogen in thyroid function and growth regulation[J]. J Thyroid Res, 2011, 2011: 875125. DOI: 10.4061/2011/875125.
[4] Heldring N, Pike A, Andersson S, et al. Estrogen receptors: how do they signal and what are their targets[J].Physiol Rev, 2007,87(3): 905-931. DOI: 10.1152/physrev.00026.2006.
[5] Vivacqua A, Bonofiglio D, Albanito L, et al. 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30[J]. Mol Pharmacol, 2006, 70(4): 1414-1423.DOI:10.1124/mol.106.026344
[6] Toran-Allerand CD, Guan X, MacLusky NJ, et al. ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury[J]. J Neurosci, 2002, 22(19): 8391-8401.
[7] Magri F, Capelli V, Rotondi M, et al. Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patient's risk[J]. Endocr Relat Cancer, 2012, 19(4): 463-471.DOI:10.1530/ERC-11-0389.
[8] Heikkilä A, Hagström J, Maenpä H, et al. Loss of estrogen receptor beta expression in follicular thyroid carcinoma predicts poor outcome[J]. Thyroid, 2013, 23(4): 456-465. DOI: 10.1089/thy.2012.0363.
[9] Huang Y, Dong W, Li J, et al. Differential expression patterns and clinical significance of estrogen receptor-alpha and beta in papillary thyroid carcinoma[J]. BMC Cancer, 2014, 14: 383. DOI: 10.1186/1471-2407-14-383.
[10] Xu S, Chen G, Peng W, et al. Oestrogen action on thyroid progenitor cells: relevant for the pathogenesis of thyroid nodules [J]. J Endocrinol, 2013, 218(1): 125-133. DOI: 10.1530/JOE-13-0029.
[11] Zeng Q, Chen GG, Vlantis AC, et al. Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway [J]. Cell Prolif, 2007, 40(6): 921-935. DOI:10.1111/j.1365-2184.2007.00471.x.
[12] Kumar A, Klinge CM, Goldstein RE. Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta[J]. Int J Oncol, 2010, 36(5): 1067-1080. DOI: 10.3892/ijo_00000588.
[13] Rajoria S, Suriano R, Shanmugam A, et al. Metastatic phenotype is regulated by estrogen in thyroid cells[J]. Thyroid, 2010, 20(1): 33-41. DOI: 10.1089/thy.2009.0296.
[14] Saji M, Ringel MD. The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors[J]. Mol Cell Endocrinol, 2010, 321(1): 20-28. DOI: 10.1016/j.mce.2009.10.016.
[15] Ciampi R, Nikiforov YE. RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis[J]. Endocrinology, 2007, 148(3): 936-941. DOI: http://dx.doi.org/10.1210/en.2006-0921.
[16] Furlanetto TW, Nunes RB Jr, Sopelsa AM, et al. Estradiol decreases iodide uptake by rat thyroid follicular FRTL-5 cells[J]. Braz J Med Biol Res, 2001, 34(2): 259-263. DOI: http://dx.doi.org/10.1590/S0100-879X2001000200015.
[17] Kalluri R, Weinberg RA. The basics of epithelial–mesenchymal transition[J]. J Clin Invest, 2009, 119: 1420-1428. DOI: 10.1172/JCI39104.
[18] Fillmore CM, Gupta PB, Rudnick JA, et al. Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling[J]. PNAS, 2010, 107: 21737-21742. DOI: 10.1073/pnas.1007863107.
[19] Todaro M, Iovino F, Eterno V, et al. Tumorigenic and metastatic activity of human thyroid cancer stem cells[J]. Can Res, 2010, 70: 8874-8885. DOI: 10.1158/0008-5472.CAN-10-1994.
[20] Malanchi I, Santamaria-Martinez A, Susanto E, et al. Interactions between cancer stem cells and their niche govern metastatic colonization[J]. Nature, 2011, 481: 85-89. DOI: 10.1038/nature10694.
[21] Mauro LV, Dalurzo M, Carlini MJ, et al. Estrogen receptor beta and epidermal growth factor receptor as early-stage prognostic biomarkers of non-small cell lung cancer[J]. Oncol Rep, 2010, 24(5): 1331-1338. DOI: 10.3892/or_00000990.
[22] Halon A, Nowak-Markwitz E, Maciejczyk A, et al. Loss of estrogen receptor beta expression correlates with shorter overall survival and lack of clinical response to chemotherapy in ovarian cancer patients[J]. Anticancer Res, 2011, 31(2): 711-718.

相似文献/References:

[1]孙树凯 翟玉娥 田清武 赵鹏 申井利 翟木绪.雌激素受体基因多态性与妊娠糖尿病的 相关性研究[J].国际内分泌代谢杂志,2018,38(06):361.[doi:10.3760/cma.j.issn.1673-4157.2018.06.001]
　Sun Shukai*,Zhai Yu'e,Tian Qingwu,et al.Correlation between polymorphism of estrogen receptor gene and gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(04):361.[doi:10.3760/cma.j.issn.1673-4157.2018.06.001]
[2]张亦涵,徐浣白.雌激素及其信号通路与甲状腺乳头状癌关系的研究进展[J].国际内分泌代谢杂志,2023,43(03):225.[doi:10.3760/cma.j.cn121383-20220501-05001]
　Zhang Yihan,Xu Huanbai..Clinical features and role of estrogen/estrogen receptor in papillary thyroid carcinoma in women[J].International Journal of Endocrinology and Metabolism,2023,43(04):225.[doi:10.3760/cma.j.cn121383-20220501-05001]

备注/Memo

备注/Memo:
通信作者:刘超,Email:liuchao@nfmcn.com
更新日期/Last Update: 2016-09-20